Quick Links

Waking Beta Cells

Waking Beta Cells

We are recruiting Seattle-area adults to test whether two drugs, liraglutide and golimumab, can temporarily “wake-up” beta-cells in type 1 diabetes patients with longstanding diabetes.

Participant Eligibility

You may be eligible if you:
• were diagnosed with type 1 diabetes at least three years ago
• are age 18 through 50
• live in the Seattle area
• are in good general health

If you are found to be eligible, you will visit our Seattle clinic three or four times during a two-month period, and administer the study drug at home between visits. You may choose to participate in the liraglutide study, golimumab study, or both (given a 90-day washout period between the first and second study drugs).

Contact

Nancy Wickstrom
(206) 287-5633

Additional Study Details

Full Study Title
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D

Study ID: BRI 18044
Start Date: 08/15/2018
End Date: 06/30/2020

Investigator(s)
Carla Greenbaum, MD

Accepts Healthy Volunteers?
No

Study Site(s)

Benaroya Research Institute

1201 Ninth Avenue
Seattle, Washington 98101



Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.

SITE PARTNERS
uw-footer